|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT02217553 |
|
Date of registration:
|
12/08/2014 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
The Effect of Vitamin D Supplementation on HIV-associated Platelet Hyperreactivity
|
|
Scientific title:
|
The Effect of Vitamin D Supplementation on HIV-associated Platelet Hyperreactivity |
|
Date of first enrolment:
|
December 2013 |
|
Target sample size:
|
50 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT02217553 |
|
Study type:
|
Interventional |
|
Study design:
|
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Indonesia
| | | | | | | |
|
Contacts
|
|
Name:
|
Quirijn de Mast, Doctor |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Radboud University |
|
|
Name:
|
Andre van der Ven, Professor |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Radboud University |
|
|
Name:
|
Agnes R Indrati, Doctor |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Universitas Padjadjaran |
|
|
Name:
|
Rudi Wisaksana, Doctor |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Universitas Padjadjaran |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- >18 years
- Treated with suppressive first-line ART for at least 12 months
- Compliant to ART and procedures of Teratai clinic
- No signs or symptoms
Exclusion Criteria:
- Use of aspirin or other platelet function inhibitors.
- Any sign or symptom
- Known active opportunistic infection
- Active illicit drug users or any other comorbidity
- History of failing ART or non-compliance.
- Pregnancy
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Vitamin D Deficiency
|
|
Blood Platelet Disorders
|
|
Intervention(s)
|
|
Drug: Cholecalciferol
|
|
Primary Outcome(s)
|
|
The effect of vitamin D supplementation on HIV-associated platelet hyperreactivity
[Time Frame: Three months]
|
|
Secondary Outcome(s)
|
|
The effect of vitamin D supplementation in platelet-monocyte aggregate formation
[Time Frame: three months]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|